80 related articles for article (PubMed ID: 8042031)
1. Granisetron (Kytril) clinical safety and tolerance.
Dilly S
Semin Oncol; 1994 Jun; 21(3 Suppl 5):10-4. PubMed ID: 8042031
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function.
Palmer R
Semin Oncol; 1994 Jun; 21(3 Suppl 5):22-5. PubMed ID: 8042033
[No Abstract] [Full Text] [Related]
3. The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis.
Perez EA; Gandara DR
Semin Oncol; 1994 Jun; 21(3 Suppl 5):15-21. PubMed ID: 8042032
[No Abstract] [Full Text] [Related]
4. A granisetron patch (sancuso).
Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):103-4; quiz p 2 following 104. PubMed ID: 19078867
[No Abstract] [Full Text] [Related]
5. Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics.
Eisenberg PD
Semin Oncol; 1994 Jun; 21(3 Suppl 5):26-9. PubMed ID: 8042034
[No Abstract] [Full Text] [Related]
6. Granisetron to prevent vomiting after cancer chemotherapy.
Med Lett Drugs Ther; 1994 Jul; 36(926):61-2. PubMed ID: 8015512
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
8. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
9. Granisetron.
Nodoushani M
Conn Med; 1995 Apr; 59(4):209-11. PubMed ID: 7606907
[No Abstract] [Full Text] [Related]
10. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
[TBL] [Abstract][Full Text] [Related]
11. [Effect of granisetron in preventing emesis due to anti-cancer drug (CDDP) administration pulmo-mediastinal malignancies--comparison of simultaneous infusion with the conventional method of administration].
Nakahara K; Minami M; Yasumitsu T; Ikeda M; Ohta M; Nakamura K; Akashi A; Kido T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):571-6. PubMed ID: 9530364
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Takada M; Furuse K; Fukuoka M; Kawahara M; Negoro S; Kusunoki Y; Ogawara M; Furue H
Gan To Kagaku Ryoho; 1997 Jun; 24(8):987-94. PubMed ID: 9212809
[TBL] [Abstract][Full Text] [Related]
14. The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
Carmichael J; Harris AL
Cancer Chemother Pharmacol; 2004 Feb; 53(2):123-8. PubMed ID: 14634790
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
Yoshiya N; Kodama S; Tanaka K; Hataya I; Tokunaga A; Takeuchi Y; Hanaoka J; Yanase T; Takahashi T; Maruhashi T
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1641-6. PubMed ID: 8060140
[TBL] [Abstract][Full Text] [Related]
16. [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
Mabro M; Cohn R; Zanesco L; Madon E; Hahlen K; Margueritte G; Breatnach F; Gentet JC; Plouvier é
Bull Cancer; 2000 Mar; 87(3):259-64. PubMed ID: 10779814
[TBL] [Abstract][Full Text] [Related]
17. Granisetron: is there a dose-response effect on nausea and vomiting?
Minami M
Cancer Chemother Pharmacol; 2003 Aug; 52(2):89-98. PubMed ID: 12783208
[TBL] [Abstract][Full Text] [Related]
18. [Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
Hirota T; Shimizu H; Fujimoto T; Koike A; Kojima T; Noguchi M; Yabushita H; Kato R; Daimaru O; Noda A
Gan To Kagaku Ryoho; 1994 Jan; 21(1):91-6. PubMed ID: 8291920
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus injection].
Tsudo M; Moriguchi T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1747-53. PubMed ID: 9757201
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
